Multimodality Imaging Probe for Positron Emission Tomography and Fluorescence Imaging Studies
Our goal is to develop multimodality imaging agents for use in cell tracking studies by positron emission tomography (PET) and optical imaging (OI). For this purpose, bovine serum albumin (BSA) was complexed with biotin (histologic studies), 5(6)- carboxyfluorescein, succinimidyl ester (FAM SE) (OI...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2014-05-01
|
| Series: | Molecular Imaging |
| Online Access: | https://doi.org/10.2310/7290.2014.00005 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841563227768487936 |
|---|---|
| author | Suresh K. Pandey Jasmeet Kaur Balu Easwaramoorthy Ankur Shah Robert Coleman Jogeshwar Mukherjee |
| author_facet | Suresh K. Pandey Jasmeet Kaur Balu Easwaramoorthy Ankur Shah Robert Coleman Jogeshwar Mukherjee |
| author_sort | Suresh K. Pandey |
| collection | DOAJ |
| description | Our goal is to develop multimodality imaging agents for use in cell tracking studies by positron emission tomography (PET) and optical imaging (OI). For this purpose, bovine serum albumin (BSA) was complexed with biotin (histologic studies), 5(6)- carboxyfluorescein, succinimidyl ester (FAM SE) (OI studies), and diethylenetriamine pentaacetic acid (DTPA) for chelating gallium 68 (PET studies). For synthesis of BSA-biotin-FAM-DTPA, BSA was coupled to (+)-biotin N-hydroxysuccinimide ester (biotin-NHSI). BSA- biotin was treated with DTPA-anhydride and biotin-BSA-DTPA was reacted with FAM. The biotin-BSA-DTPA-FAM was reacted with gallium chloride 3 to 5 mCi eluted from the generator using 0.1 N HCl and was passed through basic resin (AG 11 A8) and 150 mCi (100 μL, pH 7–8) was incubated with 0.1 mg of FAM conjugate (100 μL) at room temperature for 15 minutes to give 66 Ga-BSA-biotin-DTPA-FAM. A shaved C57 black mouse was injected with FAM conjugate (50 μL) at one flank and FAM- 68 Ga (50 μL, 30 mCi) at the other. Immediately after injection, the mouse was placed in a fluorescence imaging system (Kodak In-Vivo F, Bruker Biospin Co., Woodbridge, CT) and imaged (Λ ex : 465 nm, Λ em : 535 nm, time: 8 seconds, Xenon Light Source, Kodak). The same mouse was then placed under an Inveon microPET scanner (Siemens Medical Solutions, Knoxville, TN) injected (intravenously) with 25 μCi of 18 F and after a half-hour (to allow sufficient bone uptake) was imaged for 30 minutes. Molecular weight determined using matrix-associated laser desorption ionization (MALDI) for the BSA sample was 66,485 Da and for biotin-BSA was 67,116 Da, indicating two biotin moieties per BSA molecule; for biotin-BSA-DTPA was 81,584 Da, indicating an average of 30 DTPA moieties per BSA molecule; and for FAM conjugate was 82,383 Da, indicating an average of 1.7 fluorescent moieties per BSA molecule. Fluorescence imaging clearly showed localization of FAM conjugate and FAM- 68 Ga at respective flanks of the mouse, whereas only a hot spot at the expected flank (FAM- 68 Ga injection site) was observed in microPET imaging. Our results suggest that BSA-biotin-DTPA-FAM may function as a multiprobe for PET and fluorescence imaging. Experiments are currently in progress to demonstrate cell tracking using both optical and nuclear imaging. |
| format | Article |
| id | doaj-art-8b24f9444b8e46e19ed5cf2258b57c15 |
| institution | Kabale University |
| issn | 1536-0121 |
| language | English |
| publishDate | 2014-05-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Molecular Imaging |
| spelling | doaj-art-8b24f9444b8e46e19ed5cf2258b57c152025-01-03T00:10:27ZengSAGE PublishingMolecular Imaging1536-01212014-05-011310.2310/7290.2014.0000510.2310_7290.2014.00005Multimodality Imaging Probe for Positron Emission Tomography and Fluorescence Imaging StudiesSuresh K. PandeyJasmeet KaurBalu EaswaramoorthyAnkur ShahRobert ColemanJogeshwar MukherjeeOur goal is to develop multimodality imaging agents for use in cell tracking studies by positron emission tomography (PET) and optical imaging (OI). For this purpose, bovine serum albumin (BSA) was complexed with biotin (histologic studies), 5(6)- carboxyfluorescein, succinimidyl ester (FAM SE) (OI studies), and diethylenetriamine pentaacetic acid (DTPA) for chelating gallium 68 (PET studies). For synthesis of BSA-biotin-FAM-DTPA, BSA was coupled to (+)-biotin N-hydroxysuccinimide ester (biotin-NHSI). BSA- biotin was treated with DTPA-anhydride and biotin-BSA-DTPA was reacted with FAM. The biotin-BSA-DTPA-FAM was reacted with gallium chloride 3 to 5 mCi eluted from the generator using 0.1 N HCl and was passed through basic resin (AG 11 A8) and 150 mCi (100 μL, pH 7–8) was incubated with 0.1 mg of FAM conjugate (100 μL) at room temperature for 15 minutes to give 66 Ga-BSA-biotin-DTPA-FAM. A shaved C57 black mouse was injected with FAM conjugate (50 μL) at one flank and FAM- 68 Ga (50 μL, 30 mCi) at the other. Immediately after injection, the mouse was placed in a fluorescence imaging system (Kodak In-Vivo F, Bruker Biospin Co., Woodbridge, CT) and imaged (Λ ex : 465 nm, Λ em : 535 nm, time: 8 seconds, Xenon Light Source, Kodak). The same mouse was then placed under an Inveon microPET scanner (Siemens Medical Solutions, Knoxville, TN) injected (intravenously) with 25 μCi of 18 F and after a half-hour (to allow sufficient bone uptake) was imaged for 30 minutes. Molecular weight determined using matrix-associated laser desorption ionization (MALDI) for the BSA sample was 66,485 Da and for biotin-BSA was 67,116 Da, indicating two biotin moieties per BSA molecule; for biotin-BSA-DTPA was 81,584 Da, indicating an average of 30 DTPA moieties per BSA molecule; and for FAM conjugate was 82,383 Da, indicating an average of 1.7 fluorescent moieties per BSA molecule. Fluorescence imaging clearly showed localization of FAM conjugate and FAM- 68 Ga at respective flanks of the mouse, whereas only a hot spot at the expected flank (FAM- 68 Ga injection site) was observed in microPET imaging. Our results suggest that BSA-biotin-DTPA-FAM may function as a multiprobe for PET and fluorescence imaging. Experiments are currently in progress to demonstrate cell tracking using both optical and nuclear imaging.https://doi.org/10.2310/7290.2014.00005 |
| spellingShingle | Suresh K. Pandey Jasmeet Kaur Balu Easwaramoorthy Ankur Shah Robert Coleman Jogeshwar Mukherjee Multimodality Imaging Probe for Positron Emission Tomography and Fluorescence Imaging Studies Molecular Imaging |
| title | Multimodality Imaging Probe for Positron Emission Tomography and Fluorescence Imaging Studies |
| title_full | Multimodality Imaging Probe for Positron Emission Tomography and Fluorescence Imaging Studies |
| title_fullStr | Multimodality Imaging Probe for Positron Emission Tomography and Fluorescence Imaging Studies |
| title_full_unstemmed | Multimodality Imaging Probe for Positron Emission Tomography and Fluorescence Imaging Studies |
| title_short | Multimodality Imaging Probe for Positron Emission Tomography and Fluorescence Imaging Studies |
| title_sort | multimodality imaging probe for positron emission tomography and fluorescence imaging studies |
| url | https://doi.org/10.2310/7290.2014.00005 |
| work_keys_str_mv | AT sureshkpandey multimodalityimagingprobeforpositronemissiontomographyandfluorescenceimagingstudies AT jasmeetkaur multimodalityimagingprobeforpositronemissiontomographyandfluorescenceimagingstudies AT balueaswaramoorthy multimodalityimagingprobeforpositronemissiontomographyandfluorescenceimagingstudies AT ankurshah multimodalityimagingprobeforpositronemissiontomographyandfluorescenceimagingstudies AT robertcoleman multimodalityimagingprobeforpositronemissiontomographyandfluorescenceimagingstudies AT jogeshwarmukherjee multimodalityimagingprobeforpositronemissiontomographyandfluorescenceimagingstudies |